10 (10mg Label)
Vilazodone
Product Images NDC 42291-950
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vilazodone (NDC 42291-950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
20 (20mg Label)
40 (40mg Label)
The Structural Formula For Vilazodone HCl (Vilazodone Tablets 01)
Figure 1. Effect Of Other Drugs On Vilazodone Pharmacokinetics (Vilazodone Tablets 02)
The text mentions changes in relation to PK Fold Change and 90% C1 with respect to various substances like Ethanol, CYP3A4 Inhibitors such as Ketoconazole, Proton Pump Inhibitors like Pantoprazole, and provides data related to Cmax and Auc levels. It seems to be discussing the impact of different substances on pharmacokinetics.*
Figure 2. Impact Of Vilazodone On Other Drug Pharmacokinetics (Vilazodone Tablets 03)
Figure 3: Impact Of Intrinsic Factors On Vilazodone Pharmacokinetics (Vilazodone Tablets 04)
Population Description K Fold Change and 90% CI.
This text seems to contain information about population characteristics, including age groups, gender, renal impairment levels, and hepatic impairment levels, along with K Fold Change data and 90% Confidence Intervals. It also references changes relative to a reference with values shown on a graph or table. The data appears to be organized in a structured format for analysis or comparison.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
